Association of steatotic liver disease with long-term oncological outcomes after hepatic resection for hepatocellular carcinoma
Global Health & Medicine · 31.10.2026 · 8 (5) · 363-370
DOI: 10.35772/ghm.2026.01056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Global Health & Medicine, erschienen am 31.10.2026. Verfasst von Nobuhiro Hasui und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Kyorin University School of Medicine, Mitaka, Tokyo, Japan. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Hepatic steatosis manifests in obesity and systemic metabolic disorders. The nomenclature has recently shifted from nonalcoholic fatty liver disease/nonalcoholic steatohepatitis to steatotic liver disease (SLD), which includes metabolic dysfunction-associated steatotic liver disease, metabolic dysfunction-associated steatotic liver disease with increased alcohol intake, and alcohol-related liver disease. This study retrospectively evaluated the association between SLD and long-term oncological outcomes in 85 patients undergoing hepatic resection for hepatocellular carcinoma (HCC) between 2018 and 2022. SLD was histologically defined as steatosis involving ≥ 5% of non-tumorous hepatocytes. Of these patients, 47 did not have SLD (non-SLD group) and 38 had SLD. We compared recurrence-free survival (RFS) and overall survival (OS) between these groups. Patients with SLD exhibited a higher body mass index and more advanced fibrosis than those without SLD, whereas lifestyle-related diseases were comparably prevalent. Median RFS was not reached in the non-SLD group and was 21 months in the SLD group (log-rank p = 0.054). In exploratory multivariable analysis, SLD was associated with a higher cause-specific hazard of recurrence after adjustment for age, Barcelona Clinic Liver Cancer stage, viral hepatitis status, and diabetes mellitus (adjusted hazard ratio, 1.939; 95% confidence interval, 1.003-3.748). No significant association between SLD and OS was noted (hazard ratio, 0.962; 95% confidence interval, 0.399-2.315). These findings suggest a possible association between SLD and HCC recurrence after hepatic resection, whereas its association with OS remains uncertain.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Kyorin University School of Medicine, Mitaka, Tokyo, Japan.
- Division of Hepato-Biliary and Pancreatic Surgery, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan.
- Department of Pathology, Kyorin University School of Medicine, Mitaka, Tokyo, Japan.
- Department of Surgery, Kyorin University Suginami Hospital, Tokyo, Japan.
Zitieren
APA
Hasui, N., Funakoshi, S., Yamazaki, A., Yanase, T., Kudo, S., Momose, H., Matsuki, R., Kogure, M., Hayashi, A., Suzuki, Y., Shibahara, J., & Sakamoto, Y. (2026). Association of steatotic liver disease with long-term oncological outcomes after hepatic resection for hepatocellular carcinoma. Global Health & Medicine, 8(5), 363-370. https://doi.org/10.35772/ghm.2026.01056
Vancouver
Hasui N, Funakoshi S, Yamazaki A, Yanase T, Kudo S, Momose H, et al. Association of steatotic liver disease with long-term oncological outcomes after hepatic resection for hepatocellular carcinoma. Global Health & Medicine. 2026;8(5):363-370. doi:10.35772/ghm.2026.01056
BibTeX
@article{Hasui2026,
author = {Hasui, Nobuhiro and Funakoshi, Saori and Yamazaki, Aya and Yanase, Takuya and Kudo, Shohei and Momose, Hirokazu and Matsuki, Ryota and Kogure, Masaharu and Hayashi, Akimasa and Suzuki, Yutaka and Shibahara, Junji and Sakamoto, Yoshihiro},
title = {Association of steatotic liver disease with long-term oncological outcomes after hepatic resection for hepatocellular carcinoma},
journal = {Global Health & Medicine},
year = {2026},
volume = {8},
number = {5},
pages = {363--370},
doi = {10.35772/ghm.2026.01056}
}
EUVIMED